Eur Rev Med Pharmacol Sci 2021; 25 (5): 2193-2198

DOI: 10.26355/eurrev_202103_25210

Progress of radiotherapy after breast-conserving surgery combined with silicone prosthesis reconstruction

L. Zeng, X.-Q. Xie, T. Luo, H. Zhang, J.-B. Kang, F. Wang, X.-F. Li

Cancer Center, West China Hospital, Sichuan University, Chengdu, China. wangfeng5024@126.com


Breast cancer is the malignant tumor with the highest incidence in women. The standard treatment for early breast cancer is radical surgery combined with radiotherapy, but many studies have shown that adjuvant radiotherapy after breast-conserving surgery combined with silicone prosthesis reconstruction is gradually expected to become the new standard treatment because this method can obtain a good local tumor control rate, and has a cosmetic effect. Compared with myocutaneous flap reconstruction, silicone prosthesis implantation has the advantages of less trauma, simple operation, beautiful appearance, and no overlap of donor areas during reconstruction. It is a safe and feasible surgical method without worrying about necrosis and atrophy of myocutaneous flap. This emerging combination therapy may become the best mode of early breast cancer treatment.

Free PDF Download

To cite this article

L. Zeng, X.-Q. Xie, T. Luo, H. Zhang, J.-B. Kang, F. Wang, X.-F. Li
Progress of radiotherapy after breast-conserving surgery combined with silicone prosthesis reconstruction

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 5
Pages: 2193-2198
DOI: 10.26355/eurrev_202103_25210